KRN5500
Term · Oncology and biomedicine · MLC-T-ONC-004668
An anticancer drug that is a type of antitumor antibiotic. It is an anthracycline.
A semisynthetic derivative of the nucleoside-like antineoplastic antibiotic spicamycin, originally isolated from the bacterium Streptomyces alanosinicus. KRN 5500 inhibits protein synthesis by interfering with endoplasmic reticulum and Golgi apparatus functions. This agent also induces cell differentiation and caspase-dependent apoptosis.
| Identifier | MLC-T-ONC-004668 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-004668",
"term": "KRN5500",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that is a type of antitumor antibiotic. It is an anthracycline.",
"A semisynthetic derivative of the nucleoside-like antineoplastic antibiotic spicamycin, originally isolated from the bacterium Streptomyces alanosinicus. KRN 5500 inhibits protein synthesis by interfering with endoplasmic reticulum and Golgi apparatus functions. This agent also induces cell differentiation and caspase-dependent apoptosis."
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/krn5500/"
}
Record 9,836 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.